Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells - Ruella, Marco; Barrett, David M; Kenderian, Saad S; Shestova, Olga; Hofmann, Ted J; Scholler, John; Lacey, Simon F; Melenhorst, Jan J; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David A; Hunter, Christopher A; et al. (Journal for immunotherapy of cancer, 2015)
Keywords: Antigens; Cancer; Immunology; Immunotherapy; Leukemia; Lymphocytes; Medicine; Medicine & Public Health; Oncology; Oral Presentation; CART19 Treatment; Leukemia Stem Cell; Acute Myeloid Leukemia; CART123 Cell; Chimeric Antigen Receptor